Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Cardiovascular Disorders
Published in: BMC Cardiovascular Disorders 1/2013

Open Access 01-12-2013 | Research article

Hypertension awareness, treatment and control in Africa: a systematic review

Authors: James Kayima, Rhoda K Wanyenze, Achilles Katamba, Elli Leontsini, Fred Nuwaha

Published in: BMC Cardiovascular Disorders | Issue 1/2013

Login to get access

Abstract

Background

Inadequate diagnosis and suboptimal control of hypertension is a major driver of cardiovascular morbidity and mortality in Africa. Understanding the levels of awareness, treatment and control of hypertension and the associated factors has important implications for hypertension control efforts.

Methods

The PubMed database was searched for original articles related to awareness, treatment and control of hypertension in Africa published between 1993 and 2013. The key search terms were: Africa, awareness, treatment, control, and hypertension. Exploration of bibliographies cited in the identified articles was done to provide further studies. Full texts of the articles were obtained from various internet sources and individual authors. A data extraction sheet was used to collect this information.

Results

Thirty eight studies drawn from 23 African countries from all regions of the continent met the inclusion criteria. The levels of awareness, treatment and control varied widely from country to country. Rural populations had lower levels of awareness than urban areas. North African countries had the highest levels of treatment in the continent. There was generally poor control of hypertension across the region even among subjects that were aware of their status and those that were treated. On the whole, the women had a better control status than the men.

Conclusion

There are low levels of awareness and treatment of hypertension and even lower levels of control. Tailored research is required to uncover specific reasons behind these low levels of awareness and treatment, and especially control, in order to inform policy formulation for the improvement of outcomes of hypertensive patients in Africa.
Appendix
Available only for authorised users
Literature
1.
Gaziano TA: Cardiovascular disease in the developing world and its cost-effective management. Circulation. 2005, 112 (23): 3547-3553. 10.1161/CIRCULATIONAHA.105.591792.CrossRefPubMed
2.
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL: Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006, 367 (9524): 1747-1757. 10.1016/S0140-6736(06)68770-9.CrossRefPubMed
3.
Alwan A: Global status report on noncommunicable diseases 2010. 2011, Geneva: World Health Organization
4.
Unwin N, Commentary: Non-communicable disease and priorities for health policy in sub-Saharan Africa. Health policy and planning. 2001, 16 (4): 351-10.1093/heapol/16.4.351.CrossRefPubMed
5.
Bertrand E: Cardiovascular Disease in Developing Countries. 1999, New York, NY: McGraw-Hill
6.
Brundtland GH: The World Health Report 2002: reducing risks, promoting healthy life. 2002, Geneva: World Health Organization
7.
Gaziano TA, Bitton A, Anand S, Weinstein MC: The global cost of nonoptimal blood pressure. Journal of hypertension. 2009, 27 (7): 1472-10.1097/HJH.0b013e32832a9ba3.CrossRefPubMed
8.
Gu Q, Dillon CF, Burt VL, Gillum RF: Association of hypertension treatment and control with all-cause and cardiovascular disease mortality among US adults with hypertension. Am J Hypertens. 2010, 23 (1): 38-45. 10.1038/ajh.2009.191.CrossRefPubMed
9.
He FJ, MacGregor GA: Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year. J Hum Hypertens. 2003, 17 (7): 455-457. 10.1038/sj.jhh.1001581.CrossRefPubMed
10.
Collins R, MacMahon S: Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull. 1994, 50 (2): 272-298.PubMed
11.
Neal B, MacMahon S, Chapman N: Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials: blood pressure lowering treatment trialists’ collaboration. Lancet. 2000, 356 (9246): 1955-1964.CrossRefPubMed
12.
Addo J, Smeeth L, Leon DA: Hypertension in Sub-Saharan Africa. Hypertension. 2007, 50 (6): 1012-1018. 10.1161/HYPERTENSIONAHA.107.093336.CrossRefPubMed
13.
Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009, 151 (4): 264-269. 10.7326/0003-4819-151-4-200908180-00135.CrossRefPubMed
14.
Solet JL, Baroux N, Pochet M, Benoit-Cattin T, De Montera AM, Sissoko D, et al: Prevalence of type 2 diabetes and other cardiovascular risk factors in Mayotte in 2008: the MAYDIA study. Diabetes Metab. 2011, 37 (3): 201-207. 10.1016/j.diabet.2010.09.007.CrossRefPubMed
15.
Mufunda J, Mebrahtu G, Usman A, Nyarango P, Kosia A, Ghebrat Y, et al: The prevalence of hypertension and its relationship with obesity: results from a national blood pressure survey in Eritrea. J Hum Hypertens. 2006, 20 (1): 59-65. 10.1038/sj.jhh.1001924.CrossRefPubMed
16.
Muluneh AT, Haileamlak A, Tessema F, Alemseged F, Woldemichael K, Asefa M, et al: Population based survey of chronic non-communicable diseases at gilgel gibe field research center, southwest Ethiopia. Ethiop J Health Sci. 2012, 22 (S): 7-18.PubMedPubMedCentral
17.
Awoke A, Awoke T, Alemu S, Megabiaw B: Prevalence and associated factors of hypertension among adults in Gondar, Northwest Ethiopia: a community based cross-sectional study. BMC Cardiovasc Disord. 2012, 12 (113): 1471-2261.
18.
Tesfaye F, Byass P, Wall S: Population based prevalence of high blood pressure among adults in Addis Ababa: uncovering a silent epidemic. BMC Cardiovasc Disord. 2009, 9 (39): 1471-2261.
19.
van de Vijver SJ, Oti SO, Agyemang C, Gomez GB, Kyobutungi C: Prevalence, awareness, treatment and control of hypertension among slum dwellers in Nairobi, Kenya. J Hypertens. 2013, 19: 19-
20.
Jenson A, Omar AL, Omar MA, Rishad AS, Khoshnood K: Assessment of hypertension control in a district of Mombasa Kenya. Glob Public Health. 2011, 6 (3): 293-306. 10.1080/17441692.2010.510478.CrossRefPubMed
21.
Hendriks ME, Wit FW, Roos MT, Brewster LM, Akande TM, de Beer IH, et al: Hypertension in Sub-Saharan Africa: cross-sectional surveys in four rural and urban communities. PLoS One. 2012, 7 (3): 12-CrossRef
22.
Damasceno A, Azevedo A, Silva-Matos C, Prista A, Diogo D, Lunet N: Hypertension prevalence, awareness, treatment, and control in mozambique: urban/rural gap during epidemiological transition. Hypertension. 2009, 54 (1): 77-83. 10.1161/HYPERTENSIONAHA.109.132423.CrossRefPubMed
23.
Bovet P: The epidemiologic transition to chronic diseases in developing countries: cardiovascular mortality, morbidity, and risk factors in Seychelles (Indian Ocean): investigators of the Seychelles heart study. Soz Praventivmed. 1995, 40 (1): 35-43.CrossRefPubMed
24.
Bovet P, Ross AG, Gervasoni JP, Mkamba M, Mtasiwa DM, Lengeler C, et al: Distribution of blood pressure, body mass index and smoking habits in the urban population of Dar es Salaam, Tanzania, and associations with socioeconomic status. Int J Epidemiol. 2002, 31 (1): 240-247. 10.1093/ije/31.1.240.CrossRefPubMed
25.
Dewhurst MJ, Dewhurst F, Gray WK, Chaote P, Orega GP, Walker RW: The high prevalence of hypertension in rural-dwelling Tanzanian older adults and the disparity between detection, treatment and control: a rule of sixths?. J Hum Hypertens. 2012, 13 (10): 59-
26.
Edwards R, Unwin N, Mugusi F, Whiting D, Rashid S, Kissima J, et al: Hypertension prevalence and care in an urban and rural area of Tanzania. J Hypertens. 2000, 18 (2): 145-152. 10.1097/00004872-200018020-00003.CrossRefPubMed
27.
Musinguzi G, Nuwaha F: Prevalence awareness and control of hypertension in Uganda. PloS one. 2013, 4: e62236-CrossRef
28.
Pires JE, Sebastiao YV, Langa AJ, Nery SV: Hypertension in Northern Angola: prevalence, associated factors, awareness, treatment and control. BMC Publ Health. 2013, 13 (1): 90-10.1186/1471-2458-13-90.CrossRef
29.
Kamadjeu RM, Edwards R, Atanga JS, Unwin N, Kiawi EC, Mbanya JC: Prevalence, awareness and management of hypertension in Cameroon: findings of the 2003 Cameroon burden of diabetes baseline survey. J Hum Hypertens. 2006, 20 (1): 91-92. 10.1038/sj.jhh.1001936.CrossRefPubMed
30.
Dzudie A, Kengne AP, Muna WF, Ba H, Menanga A, Kouam Kouam C, et al: Prevalence, awareness, treatment and control of hypertension in a self-selected Sub-Saharan African urban population: a cross-sectional study. BMJ Open. 2012, 2 (4): 2012-001217.CrossRef
31.
Katchunga PB, M’Buyamba-Kayamba JR, Masumbuko BE, Lemogoum D, Kashongwe ZM, Degaute JP, et al: Hypertension in the adult Congolese population of Southern Kivu: results of the vitaraa study. Presse Med. 2011, 40 (6): 3-CrossRef
32.
Ngoungou EB, Aboyans V, Kouna P, Makandja R, Ecke Nzengue JE, Allogho CN, et al: Prevalence of cardiovascular disease in Gabon: a population study. Arch Cardiovasc Dis. 2012, 105 (2): 77-83. 10.1016/j.acvd.2011.12.005.CrossRefPubMed
33.
Matenga JA, Allain TJ, Wilson AO, Adamchak DJ, Senzanje B, Mushangi E, et al: Hypertension management in Zimbabwe–awareness, treatment and blood pressure control: a community-based study. S Afr Med J. 1997, 87 (10): 1371-1373.PubMed
34.
Temmar M, Labat C, Benkhedda S, Charifi M, Thomas F, Bouafia MT, et al: Prevalence and determinants of hypertension in the Algerian Sahara. J Hypertens. 2007, 25 (11): 2218-2226. 10.1097/HJH.0b013e3282dc7549.CrossRefPubMed
35.
Nejjari C, Arharbi M, Chentir MT, Boujnah R, Kemmou O, Megdiche H, et al: Epidemiological trial of hypertension in North Africa (ETHNA): an international multicentre study in Algeria, Morocco and Tunisia. J Hypertens. 2013, 31 (1): 49-62.PubMed
36.
Ibrahim MM, Rizk H, Appel LJ, el Aroussy W, Helmy S, Sharaf Y, et al: Hypertension prevalence, awareness, treatment, and control in Egypt. results from the Egyptian national hypertension project (NHP). NHP investigative team. Hypertension. 1995, 26 (6 Pt 1): 886-890.CrossRefPubMed
37.
Ben Romdhane H, Ben Ali S, Skhiri H, Traissac P, Bougatef S, Maire B, et al: Hypertension among Tunisian adults: results of the TAHINA project. Hypertens Res. 2012, 35 (3): 341-347. 10.1038/hr.2011.198.CrossRefPubMed
38.
Ben Romdhane H, Skhiri H, Bougatef S, Ennigrou S, Gharbi D, Chahed MK, et al: Hypertension prevalence, awareness, treatment and control: results from a community based survey. Tunis Med. 2005, 5: 41-46.
39.
Hammami S, Mehri S, Hajem S, Koubaa N, Frih MA, Kammoun S, et al: Awareness, treatment and control of hypertension among the elderly living in their home in Tunisia. BMC Cardiovasc Disord. 2011, 11 (65): 1471-2261.
40.
Houinato DS, Gbary AR, Houehanou YC, Djrolo F, Amoussou M, Segnon-Agueh J, et al: Prevalence of hypertension and associated risk factors in Benin. Rev Epidemiol Sante Publique. 2012, 60 (2): 95-102. 10.1016/j.respe.2011.09.010.CrossRefPubMed
41.
Agyemang C, Bruijnzeels MA, Owusu-Dabo E: Factors associated with hypertension awareness, treatment, and control in Ghana, West Africa. J Hum Hypertens. 2006, 20 (1): 67-71. 10.1038/sj.jhh.1001923.CrossRefPubMed
42.
Addo J, Amoah AG, Koram KA: The changing patterns of hypertension in Ghana: a study of four rural communities in the Ga District. Ethn Dis. 2006, 16 (4): 894-899.PubMed
43.
Amoah AG: Hypertension in Ghana: a cross-sectional community prevalence study in greater Accra. Ethn Dis. 2003, 13 (3): 310-315.PubMed
44.
Ulasi II, Ijoma CK, Onwubere BJ, Arodiwe E, Onodugo O, Okafor C: High prevalence and low awareness of hypertension in a market population in enugu, Nigeria. Int J Hypertens. 2011, 27 (869675): 869675-
45.
Oladapo OO, Salako L, Sodiq O, Shoyinka K, Adedapo K, Falase AO: A prevalence of cardiometabolic risk factors among a rural Yoruba south-western Nigerian population: a population-based survey. Cardiovasc J Afr. 2010, 21 (1): 26-31.PubMedPubMedCentral
46.
Omuemu VO, Okojie OH, Omuemu CE: Awareness of high blood pressure status, treatment and control in a rural community in Edo State. Niger J Clin Pract. 2007, 10 (3): 208-212.PubMed
47.
Ekwunife OI, Udeogaranya PO, Nwatu IL: Prevalence, awareness, treatment and control of hypertension in a nigerian population. Health. 2010, 2 (7): 731-735. 10.4236/health.2010.27111.CrossRef
48.
Macia E, Duboz P, Gueye L: Prevalence, awareness, treatment and control of hypertension among adults 50 years and older in Dakar, Senegal. Cardiovasc J Afr. 2012, 23 (5): 265-269. 10.5830/CVJA-2011-039.CrossRefPubMedPubMedCentral
49.
Yayehd K, Damorou F, Akakpo R, Tcherou T, N’Da NW, Pessinaba S, et al: Prevalence and determinants of hypertension in Lome (Togo): results of a screening in May 2011. Ann Cardiol Angeiol. 2013, 62 (1): 43-50. 10.1016/j.ancard.2012.09.006.CrossRef
50.
Maepe LM, Outhoff K: Hypertension in goldminers. S Afr Med J. 2011, 102 (1): 30-33.PubMed
51.
Malhotra R, Puoane T, Hoyo C, Hughes G, Ostbye T: Prevalence and awareness of hypertension in an urban township of South Africa: compelling need for action. Ethn Dis. 2008, 18 (4): 401-402. Autumn;18PubMed
52.
Steyn K, Bradshaw D, Norman R, Laubscher R: Determinants and treatment of hypertension in South Africans: the first demographic and health survey. S Afr Med J. 2008, 98 (5): 376-380.PubMed
53.
McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M, et al: Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. Cmaj. 2011, 183 (9): 1007-1013. 10.1503/cmaj.101767.CrossRefPubMedPubMedCentral
54.
Joynt KE, Chan D, Orav EJ, Jha AK: Insurance expansion in massachusetts did not reduce access among previously insured medicare patients. Health Aff. 2013, 32 (3): 571-578. 10.1377/hlthaff.2012.1018.CrossRef
55.
Atim C, Fleisher LK, Hatt L, Musau S, Arur A: Health Financing in Africa Today: Challenges and Opportunities. 2008, Washington, DC: Africa’s Health, Academy for Educational Developmen, and Bethesda, MD: Health Systems 20/20 Project
56.
Reckelhoff JF: Gender differences in the regulation of blood pressure. Hypertension. 2001, 37 (5): 1199-1208. 10.1161/01.HYP.37.5.1199.CrossRefPubMed
57.
Turnbull F, Woodward M, Neal B, Barzi F, Ninomiya T, Chalmers J, et al: Do men and women respond differently to blood pressure-lowering treatment? results of prospectively designed overviews of randomized trials. Eur Heart J. 2008, 29 (21): 2669-2680. 10.1093/eurheartj/ehn427.CrossRefPubMed
58.
Wilkins K, Gee M, Campbell N: The difference in hypertension control between older men and women. Health Rep. 2012, 23 (4): 33-40.PubMed
59.
Keyhani S, Scobie JV, Hebert PL, McLaughlin MA: Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits. Hypertension. 2008, 51 (4): 1149-1155. 10.1161/HYPERTENSIONAHA.107.107342.CrossRefPubMed
60.
61.
Hjelm K, Nambozi G: Beliefs about health and illness: a comparison between Ugandan men and women living with diabetes mellitus. Int Nurs Rev. 2008, 55 (4): 434-441. 10.1111/j.1466-7657.2008.00665.x.CrossRefPubMed
62.
Pereira M, Lunet N, Azevedo A, Barros H: Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. Journal of hypertension. 2009, 27 (5): 963-975. 10.1097/HJH.0b013e3283282f65.CrossRefPubMed
63.
Falagas ME, Pitsouni EI, Malietzis GA, Pappas G: Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses. FASEB J. 2008, 22: 338-342.CrossRefPubMed
Metadata
Title
Hypertension awareness, treatment and control in Africa: a systematic review
Authors
James Kayima
Rhoda K Wanyenze
Achilles Katamba
Elli Leontsini
Fred Nuwaha
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2013
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-13-54

Other articles of this Issue 1/2013

BMC Cardiovascular Disorders 1/2013 Go to the issue

Study protocol

The impact of the HEART risk score in the early assessment of patients with acute chest pain: design of a stepped wedge, cluster randomised trial

Study protocol

The St. Louis African American health-heart study: methodology for the study of cardiovascular disease and depression in young-old African Americans

Research article

Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials

Research article

The relationship between training status, blood pressure and uric acid in adults and elderly

Study protocol

Targets and self-management for the control of blood pressure in stroke and at risk groups (TASMIN-SR): protocol for a randomised controlled trial

Study protocol

EARLY Treatment with azilsartan compared to ACE-inhibitors in anti-hypertensive therapy – rationale and design of the EARLY hypertension registry

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits